α1-AT/Peptide Ratio Could Lead to Better Understanding of AATD COPD
-
Alpha-1 Antitrypsin Deficiency and the Power of Physical ActivityPatients with alpha-1 antitrypsin deficiency (AATD) can significantly improve clinical outcomes by committing to a physical exercise program. -
Treating Concurrent Cystic Fibrosis and Alpha-1 Antitrypsin DeficiencyResearchers presented the case report of a neonatal boy who was diagnosed with CF and AATD, and the resulting interventions that followed. -
Examining the Least Invasive Diagnostic Procedures in Wilson Disease and AATDResearchers compare the least invasive diagnostic tests for Wilson disease and alpha-1 antitrypsin deficiency. -
The Merits of Lung Volume Reduction in Emphysema Driven by AATDLung volume reduction has been shown to provide symptomatic relief to patients with end-stage chronic obstructive pulmonary disease. -
AATD Screening Programs, Public Education, and Smoking CessationA combination of targeted screening programs and smoking cessation initiatives can turn the tide against severe AATD.
-
Bespoke Gene Therapy Consortium Offers Guidelines to Ease FDA Approval ProcessThe Bespoke Gene Therapy Consortium aims to remove bottlenecks that slow the development of adeno-associated virus gene therapies for rare diseases. -
Two Pharma Companies Pursuing Rival Therapies to Treat Liver Disease in AATDTakeda and Wave Life Sciences are testing investigational treatments for liver disease that can be caused by alpha-1 antitrypsin deficiency (AATD). -
Mereo BioPharma Plans Phase 3 Study of Alvelestat for Treatment of Severe AATDAlpha-1 antitrypsin deficiency—a pulmonary disease far more common than cystic fibrosis—has not seen a new therapy in more than a decade. -
Mexican Woman Faces AATD With Determination and CourageJennifer MacDonald, a Mexican woman with alpha-1 antitrypsin deficiency, details her struggles with this crippling rare disease. -
As Pandemic Restrictions Continue to Ease, Rare Disease Patients Still Fear COVID-19Three years after COVID-19 was declared a pandemic, rare disease patients still fear the contagion—and must deal with the fallout.
-
The Downside of PICC Line Adhesives and InfectionsAs someone with alpha-1 antitrypsin deficiency (AATD), I try to watch out for possible allergic reactions.April 26, 2024 -
Patients With AATD Must Watch Their Liver HealthI’ve written quite a bit about my lung health while managing AATD, but not as much about the effects of ATTD on the liver.April 19, 2024
-
The Worst Sleeping Positions for Patients With AATDAs someone with AATD, I have a few favorite sleeping positions. Good rest is important for everyone, but especially those who have an illness or disease.April 15, 2024 -
Insurance Coverage for AATD Infusions Denied AgainI'm pretty sure I have some post-traumatic stress from the first time my insurance dropped coverage for my AATD augmentation therapy.April 5, 2024
